首页> 美国卫生研究院文献>The EMBO Journal >Chk1 and 14‐3‐3 proteins inhibit atypical E2Fs to prevent a permanent cell cycle arrest
【2h】

Chk1 and 14‐3‐3 proteins inhibit atypical E2Fs to prevent a permanent cell cycle arrest

机译:Chk1和14-3-3蛋白抑制非典型E2Fs以防止永久性细胞周期停滞

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The atypical E2Fs, E2F7 and E2F8, act as potent transcriptional repressors of DNA replication genes providing them with the ability to induce a permanent S‐phase arrest and suppress tumorigenesis. Surprisingly in human cancer, transcript levels of atypical E2Fs are frequently elevated in proliferating cancer cells, suggesting that the tumor suppressor functions of atypical E2Fs might be inhibited through unknown post‐translational mechanisms. Here, we show that atypical E2Fs can be directly phosphorylated by checkpoint kinase 1 (Chk1) to prevent a permanent cell cycle arrest. We found that 14‐3‐3 protein isoforms interact with both E2Fs in a Chk1‐dependent manner. Strikingly, Chk1 phosphorylation and 14‐3‐3‐binding did not relocate or degrade atypical E2Fs, but instead, 14‐3‐3 is recruited to E2F7/8 target gene promoters to possibly interfere with transcription. We observed that high levels of 14‐3‐3 strongly correlate with upregulated transcription of atypical E2F target genes in human cancer. Thus, we reveal that Chk1 and 14‐3‐3 proteins cooperate to inactivate the transcriptional repressor functions of atypical E2Fs. This mechanism might be of particular importance to cancer cells, since they are exposed frequently to DNA‐damaging therapeutic reagents.
机译:非典型E2F,E2F7和E2F8充当DNA复制基因的有效转录阻遏物,使它们具有诱导永久性S期停滞并抑制肿瘤发生的能力。令人惊讶的是,在人类癌症中,非典型E2Fs的转录水平经常在增生的癌细胞中升高,这表明非典型E2Fs的抑癌功能可能会通过未知的翻译后机制来抑制。在这里,我们显示非典型的E2Fs可以被检查点激酶1(Chk1)直接磷酸化,以防止永久性细胞周期停滞。我们发现14-3-3蛋白同工型以Chk1依赖的方式与两个E2F相互作用。令人惊讶的是,Chk1磷酸化和14-3-3结合不会重新定位或降解非典型E2F,而是将14-3-3募集到E2F7 / 8目标基因启动子以可能干扰转录。我们观察到14-3-3的高水平与人类癌症中非典型E2F靶基因的转录上调密切相关。因此,我们揭示了Chk1和14-3-3蛋白协同作用来灭活非典型E2Fs的转录阻遏物功能。由于癌细胞经常暴露于破坏DNA的治疗剂中,因此这种机制对癌细胞尤其重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号